UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
| (Exact name of registrant as specified in its charter) |
| (State or other jurisdiction | (Commission | (IRS Employer | ||
| of incorporation) | File Number) | Identification No.) |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s
telephone number, including area code:
| (Former Name or Former Address, if Changed Since Last Report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act: None.
| Title of each class | Ticker symbol(s) | Name of each exchange on which registered | ||
| Not Applicable. | Not Applicable. | Not Applicable. |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
| Item 5.07. | Submission of Matters to Vote of Security Holders. |
On September 23, 2021, MariMed Inc. (the “Company”) held its 2021 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, stockholders:
| ● | re-elected the Company’s five directors to serve until the Company’s next annual meeting of stockholders or until their respective successors have been duly elected and qualified (the “Election of Directors”); | |
| ● | approved, on an advisory basis, the appointment of M&K CPAs PLLC as the Company’s independent auditors for the 2021 fiscal year (“Advisory approval of Auditors”); | |
| ● | approved an amendment to the Company’s certificate of incorporation increasing the number of authorized shares of common stock from 500,000,000 to 700,000,000 (“Charter Amendment”); and | |
| ● | approved an amendment to the Company’s Amended and Restated 2018 Stock Award and Incentive Plan (“Plan Amendment”). |
The specific votes were as follows:
| 1. | The Election of Directors: |
| VOTES | ||||||||||||
| For | WITHHELD | BROKER NON-VOTE | ||||||||||
| Robert Fireman | 171,999,064 | 1,907,012 | 77,807,366 | |||||||||
| Jon R. Levine | 172,829,547 | 1,076,529 | 77,807,366 | |||||||||
| Eva Selhub, M.D. | 172,189,723 | 1,716,353 | 77,807,366 | |||||||||
| Edward Gildea | 171,334,608 | 2,571,468 | 77,807,366 | |||||||||
| David Allen | 172,256,041 | 1,650,035 | 77,807,366 | |||||||||
| 2. | Advisory approval of Auditors: |
| VOTES | ||||
| FOR | AGAINST | ABSTAIN | ||
| 249,928,428 | 686,388 | 1,098,626 | ||
| 3. | Charter Amendment: |
| VOTES | ||||
| FOR | AGAINST | ABSTAIN | ||
| 228,672,505 | 22,120,570 | 920,367 | ||
| 4. | Plan Amendment*: |
| VOTES | ||||
| FOR | AGAINST | ABSTAIN | ||
| 164,672,361 | 7,468,891 | 1,764,824 | ||
* There were 77,807,366 broker non-votes on this matter.
* * * * *
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| MARIMED INC. | ||
| Dated: September 28, 2021 | ||
| By: | /s/ Jon R. Levine | |
| Jon R. Levine, Chief Financial Officer | ||